Ligand Pharmaceuticals Inc

LGND

Sector
Healthcare

Industry
Biotechnology

Website
ligand.com




Buy / Sell (dollars)

1 Month

57.7% 57.7% Complete (success)
42.3% 42.3% Complete (danger)
$384,580.00
avg. $384,580.00
$282,300.00
avg. $282,300.00

Buy/Sell Ratio

1.362

Transactions

5

Filers

3

3 Month

74.9% 74.9% Complete (success)
25.1% 25.1% Complete (danger)
$841,525.20
avg. $280,508.40
$282,300.00
avg. $94,100.00

Buy/Sell Ratio

2.981

Transactions

8

Filers

4

12 Month

11% 11% Complete (success)
89% 89% Complete (danger)
$6.198M
avg. $516,495.83
$50.290M
avg. $4.191M

Buy/Sell Ratio

0.123

Transactions

84

Filers

11

24 Month

8.7% 8.7% Complete (success)
91.3% 91.3% Complete (danger)
$7.894M
avg. $328,906.97
$82.708M
avg. $3.446M

Buy/Sell Ratio

0.095

Transactions

163

Filers

11

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.



Filers